No takes yet. Share an insight, caveat, or question.
Experimental findings reveal that urolithin A reduces inflammation and improves mitochondrial homeostasis in C2C12 myotubes, implying therapeutic strategy for mitochondrial dysfunction.
Tapia‐Curimil et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: